Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
CN Stock MarketDetailed Quotes
Wanbangde Pharmaceutical Holding Group (002082)
- 29.28
- +0.27+0.93%
Market Closed Apr 17 15:00 CST
17.91BMarket Cap1273.04P/E (TTM)
29.79High28.52Low451.28KlotVolume28.60Open29.01Prev Close1.32BTurnover8.16%Turnover Ratio321.76P/E (Static)611.69MShares36.2452wk High6.70P/B16.20BFloat Cap5.5152wk Low31.91Limit Up553.25MShs Float36.24Historical High26.11Limit Down4.38%Range %1.83Historical Low--Dividend TTM29.29Avg Price222.15KlotAsk--Div Yield TTM100Lot Size202.94KlotBid
Wanbangde Pharmaceutical Holding Group (002082) Income Statement
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -5.28%1.02B | -23.15%578.55M | -26.58%315.11M | -6.39%1.44B | 5.56%1.07B | 1.93%752.8M | 11.41%429.17M | -13.69%1.54B | -14.00%1.02B | 1.01%738.56M |
| Operating revenue | -5.28%1.02B | -23.15%578.55M | -26.58%315.11M | -6.39%1.44B | 5.56%1.07B | 1.93%752.8M | 11.41%429.17M | -13.69%1.54B | -14.00%1.02B | 1.01%738.56M |
| Other operating revenue | ---- | -78.59%1.17M | ---- | 53.28%16.11M | ---- | -38.51%5.48M | ---- | -36.16%10.51M | ---- | 126.46%8.91M |
| Interest income | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
| Commission income | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
| Premiums earned | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
| Total operating cost | -1.75%1.06B | -16.45%616.45M | -23.44%314.23M | -5.99%1.4B | 3.07%1.08B | 1.27%737.79M | 13.55%410.43M | -2.75%1.49B | 0.19%1.05B | 9.44%728.57M |
| Operating cost | 7.91%689.03M | -17.27%390.3M | -23.90%208.46M | -7.46%839.62M | 11.83%638.5M | 6.07%471.78M | 25.46%273.93M | 7.08%907.26M | 3.48%570.96M | 10.27%444.77M |
| Operating tax surcharges | 25.94%13.47M | 16.40%8.7M | 18.74%4.02M | -4.69%19.94M | 2.49%10.7M | 5.77%7.48M | -13.18%3.39M | -10.87%20.93M | -29.22%10.44M | -22.63%7.07M |
| Operating expense | -30.96%166.27M | -29.71%93.94M | -40.13%41.04M | -0.42%279.4M | -8.80%240.83M | -6.96%133.64M | 11.66%68.54M | -29.67%280.59M | 2.35%264.07M | 2.53%143.64M |
| Administration expense | -2.86%117.05M | -6.63%78.09M | 0.78%40.67M | -8.01%165.76M | -6.68%120.5M | -4.22%83.63M | -24.86%40.36M | -0.71%180.19M | -17.55%129.12M | 20.43%87.32M |
| Financial expense | -4.54%23.33M | 3.39%14.29M | -34.88%7.26M | -22.15%38.71M | -22.79%24.44M | -23.18%13.82M | 13.45%11.15M | 102.97%49.73M | 79.05%31.66M | 50.27%18M |
| -Interest expense (Financial expense) | ---- | 15.52%19.19M | ---- | -17.17%38.5M | ---- | -7.28%16.61M | ---- | 40.02%46.48M | ---- | 8.79%17.92M |
| -Interest Income (Financial expense) | ---- | -68.20%-5.47M | ---- | 37.90%-1.68M | ---- | -40.91%-3.25M | ---- | 73.68%-2.7M | ---- | 57.38%-2.31M |
| Research and development | 16.58%49.27M | 13.48%31.14M | -2.17%12.77M | 10.91%59.87M | 8.62%42.26M | -1.21%27.44M | -8.52%13.06M | -8.66%53.98M | -12.33%38.9M | -3.04%27.78M |
| Credit Impairment Loss | 18.20%-7.32M | 119.50%2.69M | 40.27%-4.08M | 103.81%897.88K | -78.43%-8.95M | -567.58%-13.82M | -141.07%-6.83M | 39.56%-23.56M | 73.02%-5.02M | 127.23%2.96M |
| Asset Impairment Loss | -202.05%-2.08M | -269.58%-1.09M | -149.53%-543.36K | -149.00%-27.14M | 68.95%-689.63K | 159.36%644.35K | 236.54%1.1M | 88.50%-10.9M | 66.38%-2.22M | 80.51%-1.09M |
| Other net revenue | -3.22%41.76M | 420.05%48.75M | 82.94%23.27M | 190.25%20.09M | 345.68%43.15M | -43.95%9.37M | 3,089.74%12.72M | 81.89%-22.26M | -51.01%9.68M | 410.78%16.72M |
| Fair value change income | 49.77%2.86M | -71.87%536.18K | ---- | 260.34%2.94M | 506.39%1.91M | 506.39%1.91M | ---- | -227.33%-1.83M | 45.31%-469.08K | 85.18%-469.08K |
| Invest income | --0 | ---- | 18.81%271.6K | 593.87%17.29M | -90.83%228.59K | -90.83%228.59K | -91.03%228.59K | 398.38%2.49M | 365.78%2.49M | 398.38%2.49M |
| Net open hedge income | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
| -Including: Investment income associates | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
| Exchange income | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
| Asset deal income | -98.89%297.9K | --297.9K | ---- | 12,839.79%15.74M | 38,654.29%26.92M | --0 | ---- | 112.78%121.67K | -112.04%-69.82K | -155.87%-69.82K |
| Other revenue | 102.26%48.01M | 126.90%46.32M | 51.57%27.63M | -9.31%10.36M | 58.61%23.74M | 58.22%20.41M | 1,126.52%18.23M | -3.74%11.42M | -66.52%14.97M | -5.01%12.9M |
| Operating profit | -97.42%1.04M | -55.49%10.85M | -23.22%24.16M | 122.74%60.14M | 330.09%40.41M | -8.73%24.38M | 30.09%31.46M | -79.02%27M | -110.96%-17.56M | -55.54%26.71M |
| Add:Non operating Income | 142.17%1.24M | -49.11%320.52K | -53.01%291.28K | -60.30%4.45M | 24.44%512.39K | 122.83%629.85K | 96.78%619.89K | 1,126.99%11.22M | -64.64%411.76K | -90.03%282.66K |
| Less:Non operating expense | -67.96%1.76M | -30.42%1.49M | -63.35%307.17K | -31.97%5.64M | 223.73%5.49M | 82.06%2.14M | -12.78%838.05K | -71.85%8.29M | -41.53%1.7M | -5.88%1.17M |
| Total profit | -98.52%524.01K | -57.66%9.68M | -22.74%24.14M | 96.96%58.95M | 288.02%35.43M | -11.42%22.87M | 32.74%31.25M | -70.11%29.93M | -111.89%-18.85M | -58.13%25.82M |
| Less:Income tax cost | 6.43%-760.61K | 112.53%898.61K | 105.40%12.91M | 280.19%13.71M | 92.00%-812.88K | -86.62%-7.17M | 7,892.13%6.29M | -86.36%3.6M | -151.15%-10.16M | -136.85%-3.84M |
| Net profit | -96.46%1.28M | -70.76%8.79M | -55.01%11.23M | 71.87%45.25M | 517.09%36.25M | 1.29%30.05M | 5.67%24.96M | -64.28%26.33M | -106.27%-8.69M | -42.09%29.66M |
| Net profit from continuing operation | -96.46%1.28M | -70.76%8.79M | -55.01%11.23M | 71.87%45.25M | 517.09%36.25M | 1.29%30.05M | 5.67%24.96M | -64.28%26.33M | -106.27%-8.69M | -42.09%29.66M |
| Net income from discontinuing operating | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 |
| Less:Minority Profit | 66.35%-3.18M | 38.93%-4.68M | -2.43%-3.97M | 55.46%-10.19M | -447.82%-9.46M | -297.51%-7.66M | -4.40%-3.88M | -17.01%-22.88M | 80.33%-1.73M | 67.72%-1.93M |
| Net profit of parent company owners | -90.22%4.47M | -64.29%13.46M | -47.29%15.2M | 12.66%55.44M | 756.36%45.71M | 19.36%37.7M | 5.49%28.84M | -47.23%49.21M | -104.72%-6.96M | -44.77%31.59M |
| Earning per share | ||||||||||
| Basic earning per share | -86.50%0.01 | -67.27%0.02 | -46.57%0.0249 | 12.50%0.09 | 750.00%0.0741 | 18.64%0.0611 | 5.43%0.0466 | -46.67%0.08 | -104.78%-0.0114 | -44.38%0.0515 |
| Diluted earning per share | -86.50%0.01 | -67.27%0.02 | -46.57%0.0249 | 12.50%0.09 | 750.00%0.0741 | 18.64%0.0611 | 5.43%0.0466 | -46.67%0.08 | -104.78%-0.0114 | -44.38%0.0515 |
| Other composite income | -49.13%8.74M | 197.73%8.02M | 9.86%1.92M | 106.73%1.13M | 228.32%17.19M | 131.14%2.69M | 116.27%1.75M | -336.70%-16.71M | -633.25%-13.39M | -206.25%-8.65M |
| Other composite income of parent company owners | -64.32%3.52M | 697.04%3.85M | 293.67%1.3M | 125.96%2.57M | 225.81%9.87M | 110.88%483.32K | 89.66%-672.15K | -303.25%-9.92M | -834.26%-7.84M | -185.61%-4.44M |
| Other composite income of minority owners | -28.66%5.22M | 88.54%4.17M | -74.48%617.22K | 78.67%-1.45M | 231.87%7.32M | 152.50%2.21M | 157.14%2.42M | -411.53%-6.79M | -462.27%-5.55M | -242.49%-4.21M |
| Total composite income | -81.23%10.03M | -48.67%16.81M | -50.77%13.15M | 382.21%46.37M | 341.95%53.44M | 55.81%32.74M | 107.24%26.71M | -88.09%9.62M | -116.14%-22.09M | -64.61%21.01M |
| Total composite income of parent company owners | -85.62%7.99M | -54.66%17.32M | -41.41%16.5M | 47.65%58.02M | 475.31%55.58M | 40.66%38.19M | 35.18%28.17M | -59.96%39.29M | -110.10%-14.81M | -56.48%27.15M |
| Total composite income of minority owners | 195.25%2.04M | 90.63%-510.52K | -129.75%-3.36M | 60.77%-11.64M | 70.59%-2.14M | 11.20%-5.45M | 81.62%-1.46M | -70.81%-29.68M | 25.49%-7.28M | -103.52%-6.14M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Beijing Dehao International Certified Public Accountants (Special General Partnership) | -- | -- | -- | Beijing Dahua International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm